Riskpilot← Back to searchSign inGet full accessApoLeasing A/S
A/SIn liquidationCVR 40617221Fruebjergvej 3Rental and operating of own or leased real estate · NACE 6820Est. 2019— employees
Revenue 2024
DKK -6K
-89% vs 2023
EBITDA margin
1334.8%
-38% vs 2023
Equity ratio
85.2%
Financial strength
Net profit 2024
DKK -72K
-40% vs 2023
| Revenue | DKK -6K | -89% |
| EBITDA | DKK -78K | -38% |
| Net profit | DKK -72K | -40% |
| Total assets | DKK 262K | -31% |
| Equity | DKK 223K | -24% |
| Employees | — | — |
Legal name
ApoLeasing A/S
CVR number
40617221
Legal form
Aktieselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
27. juni 2019
Share capital
DKK 451.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets hovedaktivitet er at leje og fremleje fast ejendom til brug for drift af apoteksenheder, indgåelse af samhandels- og rabataftaler med leverandører af apoteksindretning og driftsinventar samt anden hermed beslægtet virksomhed.
Address
Fruebjergvej 3
Email
apotekeren@apotekerenamba.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 16 | 25 | -53 | -58 | -53 | -6 |
| Staff expenses | -2 | -4 | -4 | -4 | -4 | -4 |
| EBITDA | 14 | 21 | -57 | -62 | -57 | -78 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 14 | 21 | -57 | -62 | -57 | -78 |
| Net financials | -1 | -3 | -4 | -4 | 5 | 6 |
| Profit before tax | 13 | 18 | -62 | -65 | -52 | -72 |
| Tax | 3 | 4 | -0 | -0 | -0 | -0 |
| Net profit | 10 | 14 | -62 | -65 | -52 | -72 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 616 | 572 | 516 | 418 | 378 | 262 |
| Equity | 461 | 475 | 413 | 348 | 296 | 223 |
| Long-term debt | 39 | 53 | 70 | 34 | 44 | 0 |
| Short-term debt | 115 | 44 | 33 | 36 | 38 | 39 |
| Total debt | 155 | 97 | 103 | 70 | 82 | 39 |
EBITDA margin
-7818200.0%
This company
15.8%
Market median
-49482378% vs market
20192024
Equity ratio
85.2%
This company
38.2%
Market median
+123% vs market
20192024
Return on equity
-32.4%
This company
18.4%
Market median
-276% vs market
20192024
Net profit margin
-7243900.0%
This company
8.1%
Market median
-89430964% vs market
20192024
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20192024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-06-27 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LB Unofficial title | Unofficial title | 2025 | — | — |
CV Unofficial title | Unofficial title | 2025 | — | — |
DB Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2019 | — | — | |
| Deputy Chairman | 2020 | — | — | |
| Deputy Chairman | 2019 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Chairman | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
APOTEKEREN A.M.B.A. | Company | 25.0% | 25.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
APOTEKEREN A.M.B.A.
ApoLeasing A/S Board members of ApoLeasing A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Louise Bertelsen Forman | Unofficial title | 0 companies |
| Christian Vinding Thomsen | Unofficial title | 0 companies |
| Dorte Brix Nagell | Chief Executive Officer | 0 companies |
| Jakob Møller | Board of Directors | 0 companies |
| Peer Nørkjær | Board of Directors | 0 companies |
| Camilla Bangert | Board of Directors | 0 companies |
| Christina Weidemann Pedersen | Board of Directors | 0 companies |
| Peder Gunnersen Harboe | Board of Directors | 0 companies |
| Niels Kristensen | Deputy Chairman | 0 companies |
| Jette Kristensen | Deputy Chairman | 0 companies |
| Michael Bobak | Board of Directors | 0 companies |
| Per Wijngaard | Deputy Chairman | 0 companies |
| Trine Frost Hansen | Chairman | 0 companies |
| Kristian Østergaard Nielsen | Board of Directors | 0 companies |
| Peter Oksbjerg Krüger Bak | Board of Directors | 0 companies |